Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

NCT01036087 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Panitumumab
DRUG: Nab-paclitaxel
DRUG: Carboplatin
DRUG: 5-Fluorouracil
DRUG: Epirubicin
DRUG: Cyclophosphamide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]